Tag: ramucirumab

Cyramza – Ramucirumab uses, dose and side effects

Cyramza is a cancer drug that contains the active substance ramucirumab which is a monoclonal antibody. It is a specialized protein that can recognize and attach to another protein in the blood vessels called “VEGF receptor 2”. This receptor is needed for the development of new blood vessels. For cancer to grow, new blood vessels must be developed. By attaching to and blocking “VEGF receptor 2”, this drug cuts off the blood supply to the cancer cells.

Read More